Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-27

Clinical Trial Update: Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model

View source ↗

Summary

An ongoing study evaluated an anti-TREM-1 therapy in an ex vivo human intestinal model for inflammatory bowel disease, with recruitment currently open.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-TREM-1 treatment (TREM-1 inhibitor)

Snippet

Sponsor: Inotrem | Conditions: Inflammatory Bowel Diseases | Status: RECRUITING